These results demonstrate that Gdpd3 deficiency promotes the cell cycle progression of CML stem/progenitor cells, and thus breaks the quiescence essential for maintaining the stemness of CML stem cells in vivo. Here, GDPD3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.